The Drug Quality and Security Act (DQSA) of 2013 has laid the groundwork for a comprehensive system designed to identify and trace certain prescription drugs throughout the United States. As we approach the ten-year mark since its enactment, the implementation of an electronic, interoperable system is set to enhance the exchange of critical information among stakeholders in the pharmaceutical supply chain.
This development is significant for regulatory, quality assurance, and supply chain professionals as it aims to bolster drug safety and integrity. By establishing a robust framework for tracking pharmaceuticals, the DSCSA not only addresses concerns related to counterfeit drugs but also streamlines compliance processes for manufacturers and distributors. Ultimately, the successful rollout of this system will have far-reaching implications for operational efficiency and patient safety in the pharmaceutical industry.
Use the database as your supply chain compass →
